Clairvest invests in Boca Biolistics

Torys acted as counsel to Clairvest with a team led by Cheryl Reicin and that included Brook Wong and Jordan Wright (corporate/life sciences), Jonathan Wiener and Ben Pan (lending), Ellie Kang and Ryan Davis (employment), William Walters and Ali Harkness (privacy), Peter Keenan and Michelle Lu (tax).

On February 21, 2023, Clairvest Group Inc. (“CVG”) announced that it, together with Clairvest Equity Partners VI (“CEP VI”, collectively “Clairvest”) made a US$25 million equity investment in Boca Biolistics (“Boca”), partnering with its management team for the next phase of growth.

Boca Biolistics represents Clairvest’s second investment in the life sciences domain, as well as its 60th platform investment and 9th investment in the Clairvest / CEP VI co-investment pool which is capitalized at US$850 million.

Further information can be found on Globe Newswire’s website.

Boca Biolistics is a leading clinical research organization and biomaterials company focused on the procurement, storage, and sale of human biological samples (specializing in infectious diseases and oncology) used for clinical trials and diagnostic development.

Clairvest is a top performing private equity management firm with over C$3.3 billion of capital under management.